Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virtual Screening Techniques in Drug Discovery: Review and Recent Applications
Sheisi Fonseca Leite da Silva Rocha, Carolina G. Olanda, Harold Hilarion Fokoue, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 19, pp. 1751-1767
Closed Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation
Jean Quancard, Anna Vulpetti, Anders Bach, et al.
ChemMedChem (2023) Vol. 18, Iss. 9
Closed Access | Times Cited: 8
Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 580-580
Open Access | Times Cited: 8
Potential colchicine binding site inhibitors unraveled by virtual screening, molecular dynamics and MM/PBSA
Leonardo Bruno Federico, Guilherme Martins Silva, Suzane Quintana Gomes, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104817-104817
Open Access | Times Cited: 18
In silico design, docking simulation, and ANN-QSAR model for predicting the anticoagulant activity of thiourea isosteviol compounds as FXa inhibitors
Marcin Gackowski, Burhanuddin Madriwala, Marcin Koba
Chemical Papers (2023) Vol. 77, Iss. 11, pp. 7027-7044
Open Access | Times Cited: 7
Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway
Yueyue Li, Jia Lai, Mei Ran, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176548-176548
Closed Access | Times Cited: 2
Antifungal drug discovery for targeting Candida albicans morphogenesis through structural dynamics study
Ali A. Rabaan, Wadha Alfouzan, Mohammed Garout, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-17
Closed Access | Times Cited: 2
AutoDesigner - Core Design, a De Novo Design Algorithm for Chemical Scaffolds: Application to the Design and Synthesis of Novel Selective Wee1 Inhibitors
Pieter H. Bos, Fabio Ranalli, E. A. Flood, et al.
(2024)
Open Access | Times Cited: 2
Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors
Jinxin Che, Ruiwei Feng, Jian Gao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 20
Screening and identifying of α‐amylase inhibitors from medicine food homology plants: Insights from computational analysis and experimental studies
Chao Jiang, Li Wang, Jiajia Shao, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 12
Open Access | Times Cited: 18
Ligand- and Structure-Based Virtual Screening in Drug Discovery
Shome S. Bhunia, Mridula Saxena, Anil K. Saxena
Topics in medicinal chemistry (2021), pp. 281-339
Closed Access | Times Cited: 17
Small Molecules as Toll-like Receptor 4 Modulators Drug and In-House Computational Repurposing
Lucía Pérez-Regidor, Joan Guzman‐Caldentey, Nils Oberhauser, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2326-2326
Open Access | Times Cited: 11
Identification of Putative Drug Targets in Highly Resistant Gram-Negative Bacteria; and Drug Discovery Against Glycyl-tRNA Synthetase as a New Target
Sepideh Fereshteh, Narjes Noori Goodarzi, Hourieh Kalhor, et al.
Bioinformatics and Biology Insights (2023) Vol. 17
Open Access | Times Cited: 6
Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Rodrigo Santos Aquino de Araújo, Edeildo Ferreira da Silva‐Júnior, Thiago Mendonça de Aquino, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 19, pp. 1677-1703
Closed Access | Times Cited: 16
A strategy to discover selective α-glucosidase/acetylcholinesterase inhibitors from five function-similar citrus herbs through LC-Q-TOF-MS, bioassay and virtual screening
Hua Guo, Yuehua Chen, Tian‐Min Wang, et al.
Journal of Chromatography B (2021) Vol. 1174, pp. 122722-122722
Closed Access | Times Cited: 14
Ligand-based G Protein Coupled Receptor pharmacophore modeling: Assessing the role of ligand function in model development
Paige N. Castleman, Gregory L. Szwabowski, Dale Bowman, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 111, pp. 108107-108107
Closed Access | Times Cited: 14
Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases
Qian Li, Zhao-bin Ma, Shuhua Qin, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 12, pp. 2447-2464
Closed Access | Times Cited: 9
Screening and Molecular Mechanisms of Novel ACE-Inhibitory Peptides from Gracilariopsis lemaneiformis
Yongchang Su, Shicheng Chen, Jiashen Shen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14850-14850
Open Access | Times Cited: 9
Advances in Drug Discovery and Design using Computer-aided Molecular Modeling
Kuldeep Singh, Bharat Bhushan, Bhoopendra Singh
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 5, pp. 697-710
Closed Access | Times Cited: 5
Virtual Screening and In Vitro Experimental Verification of LuxS Inhibitors for Escherichia coli O157:H7
Yubin Bai, Xiaorong Yang, Bing Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 4
Discovery of 4-aminophenylacetamide derivatives as intestine-specific farnesoid X receptor antagonists for the potential treatment of nonalcoholic steatohepatitis
Cong Chen, Bing Zhang, Jiaojiao Tu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115992-115992
Closed Access | Times Cited: 4
In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
Calvin R. Wei, Zarrin Basharat, Godwin C. Lang’at
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 54-69
Open Access | Times Cited: 1
How should we teach medicinal chemistry in higher education to prepare students for a future career as medicinal chemists and drug designers? - A teacher´s perspective.
Philipp Klahn
(2024)
Open Access | Times Cited: 1
Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies
Matteo Pappalardo, Federica Sipala, M Nicolosi, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5349-5349
Open Access | Times Cited: 1
How Should we Teach Medicinal Chemistry in Higher Education to Prepare Students for a Future Career as Medicinal Chemists and Drug Designers? – A Teacher's Perspective
Philipp Klahn
ChemMedChem (2024)
Open Access | Times Cited: 1
Structure-Based Discovery of Dual-Target Hits for Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptors: In Silico Studies and In Vitro Confirmation
Sebastian Oddsson, Natalia M. Kowal, Philip K. Ahring, et al.
Molecules (2020) Vol. 25, Iss. 12, pp. 2872-2872
Open Access | Times Cited: 10

Scroll to top